clinical studies have shown parenteral bretylium to be effective in suppressing ventricular arrhythmias , particularly recurrent , drug resistant ventricular tachycardia or ventricular fibrillation .
C0085612
ventricular arrhythmias
C0042514
ventricular tachycardia